Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structural features required for ligand binding to the beta-adrenergic receptor.

R A Dixon1, I S Sigal, M R Candelore

  • 1Department of Virus and Cell Biology Research, Merck Sharp and Dohme Research Laboratories, West Point, PA 19486.

The EMBO Journal
|November 1, 1987
PubMed
Summary

Researchers investigated the beta-adrenergic receptor (beta AR) structure by deleting gene regions. Most hydrophilic regions are not essential for ligand binding, but specific cysteine residues are crucial for beta AR function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mutagenesis approaches for elucidation of protein structure-function relationships.

Current protocols in neuroscience·2008
Same author

Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.

Cancer research·2001
Same author

Facilitation of acetylcholine release and improvement in cognition by a selective M2 muscarinic antagonist, SCH 72788.

Life sciences·2001
Same author

Beta(3)-adrenoceptor agonist-induced increases in lipolysis, metabolic rate, facial flushing, and reflex tachycardia in anesthetized rhesus monkeys.

The Journal of pharmacology and experimental therapeutics·2001
Same author

Human beta3 adrenergic receptor agonists containing cyanoguanidine and nitroethylenediamine moieties.

Bioorganic & medicinal chemistry letters·2001
Same author

Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human beta3 adrenergic receptor agonists.

Bioorganic & medicinal chemistry letters·2000

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • The beta-adrenergic receptor (beta AR) shares homology with opsin proteins.
  • The ligand binding domain is hypothesized to be within the transmembrane hydrophobic regions.

Purpose of the Study:

  • To systematically examine the role of different regions of the beta AR in its function.
  • To identify key structural elements required for ligand binding and membrane localization.

Main Methods:

  • Sequential gene deletions were introduced into the hamster beta AR.
  • Mutant receptors were expressed in COS-7 cells for analysis.
  • Expression, cell membrane localization, and ligand binding capabilities were assessed.

Main Results:

Related Experiment Videos

  • Hydrophobic regions and adjacent hydrophilic segments are essential for beta AR processing and membrane localization.
  • Most hydrophilic regions were found to be dispensable for beta-adrenergic ligand binding.
  • Substitution of cysteine residues at positions 106 and 184 significantly altered ligand binding.

Conclusions:

  • The tertiary structure of the beta AR involves a disulfide bond between cysteine residues 106 and 184.
  • Specific structural elements are critical for receptor function, while others are more flexible.